The company said, “The Company currently anticipates 2026 total revenue of $98 million to $100 million, which contemplates growth of 20% to 22% for the underlying core RNS business compared to preliminary unaudited 2025 RNS revenue.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NPCE:
- NeuroPace reports preliminary Q4 revenue $26.6M, consensus $24.43M
- NeuroPace Initiated With Buy on Breakthrough RNS Label Expansion Opportunity and Strong NAUTILUS Efficacy Data
- NeuroPace files premarket approval supplement application for RNS System
- NeuroPace price target raised to $22 from $18 at UBS
- NeuroPace price target raised to $20 from $18 at JPMorgan